HLA-B Kit ELISA (Major Histocompatibility Complex, Class I, B)

N° du produit ABIN2043915

Détail du produit HLA-B Kit ELISA

Antigène: HLA-B

See all HLA-B Kits ELISA

Reactivité: Humain

Méthode de détection: Colorimetric

Type de méthode: Sandwich ELISA

Gamme de detection: 1.56-100 ng/mL

Seuil minimal de détection: 1.56 ng/mL

Application: ELISA

Marque: BioAssay™

Sensibilité: < 0.63 ng/mL

Information d'application

Plaque: Pre-coated

Protocole: Major Histocompatibility Complex Class I B (MHCB) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Major Histocompatibility Complex Class I B (MHCB). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Major Histocompatibility Complex Class I B (MHCB). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Major Histocompatibility Complex Class I B (MHCB), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Major Histocompatibility Complex Class I B (MHCB) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Restrictions: For Research Use only

Stockage

Stock: 4 °C/-20 °C

Détail du antigène

Antigène: HLA-B

See all HLA-B Kits ELISA

Autre désignation: Major Histocompatibility Complex Class I B (MHCB) (HLA-B ELISA Kit Extrait)

Synonymes: AS, HLAB, SPDA1, mhc1b, major histocompatibility complex, class I, B, major histocompatibility complex nonclassical class Ib L homeolog, HLA-B, BOLA-B, MAMU-B18, DKFZP469N1225, mhc1b.L

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response